Jazz Pharmaceuticals (JAZZ) R&D In Process (2016 - 2025)
Historic R&D In Process for Jazz Pharmaceuticals (JAZZ) over the last 10 years, with Q3 2025 value amounting to $42.5 million.
- Jazz Pharmaceuticals' R&D In Process changed N/A to $42.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $947.9 million, marking a year-over-year increase of 328522.14%. This contributed to the annual value of $10.0 million for FY2024, which is 4736.84% down from last year.
- As of Q3 2025, Jazz Pharmaceuticals' R&D In Process stood at $42.5 million.
- Over the past 5 years, Jazz Pharmaceuticals' R&D In Process peaked at $905.4 million during Q2 2025, and registered a low of $1.0 million during Q1 2023.
- For the 4-year period, Jazz Pharmaceuticals' R&D In Process averaged around $203.0 million, with its median value being $42.5 million (2025).
- Its R&D In Process has fluctuated over the past 5 years, first plummeted by 9520.0% in 2023, then soared by 90000.0% in 2024.
- Quarter analysis of 4 years shows Jazz Pharmaceuticals' R&D In Process stood at $375.0 million in 2022, then tumbled by 95.2% to $18.0 million in 2023, then plummeted by 44.44% to $10.0 million in 2024, then skyrocketed by 325.0% to $42.5 million in 2025.
- Its R&D In Process stands at $42.5 million for Q3 2025, versus $905.4 million for Q2 2025 and $10.0 million for Q1 2024.